局所鎮痛剤市場：薬剤クラス別、剤形別、治療用途別、疼痛タイプ別、流通別、薬剤タイプ別、薬剤組成別、性別、年齢層別、流通チャネル別、地域別

局所鎮痛剤市場は2025年に121億米ドルと推定され、2032年には185億6,000万米ドルに達すると予測され、2025～2032年までの年間平均成長率（CAGR）は6.3%で成長する見込みです。

局所鎮痛剤の世界市場は、疼痛管理医薬品業界の中でも重要なセグメントであり、様々な疼痛症状を局所的に緩和するために設計された、多様な外用治療製品を包含しています。クリーム、ゲル、パッチ、スプレー、軟膏を含む局所鎮痛剤は、経皮吸収により患部に直接有効医薬品成分を送達し、全身への曝露や関連する副作用を最小限に抑えながら、標的を絞った鎮痛を提供します。この市場は、関節炎、筋緊張、腰痛、神経障害性疼痛、スポーツ関連傷害などの急性および慢性の疼痛状態に対応し、複数の治療用途に使用されています。筋骨格系障害の有病率の増加、人口動態の高齢化、非侵襲的疼痛管理代替薬に対する消費者の嗜好の高まりが、市場拡大に大きく寄与しています。市場成長を牽引する主な有効成分には、メントール、カプサイシン、サリチル酸塩、非ステロイド性抗炎症薬、リドカインなどがあり、それぞれ鎮痛作用のメカニズムが異なります。市場には処方薬と市販薬の両方があり、多様な消費者ニーズとヘルスケア提供者の嗜好に対応しています。経皮吸収パッチやナノ製剤を含むドラッグデリバリーシステムの技術的進歩は、製品の有効性と患者のコンプライアンスを向上させ、市場開拓をさらに刺激し、革新的な治療ソリューションの機会を生み出しています。

市場力学

世界の局所鎮痛剤市場は、持続的な成長と市場拡大を後押しするいくつかの相互関連要因によって主に牽引されています。世界の高齢者人口の増加と、関節炎、線維筋痛症、神経障害性疼痛などの慢性疼痛疾患の有病率の上昇が、効果的な局所疼痛管理ソリューションに対する大きな需要を生み出しています。胃腸合併症や依存性リスクなど、経口鎮痛剤の副作用に対する意識の高まりにより、消費者やヘルスケア提供者の嗜好は、全身への曝露を減らし局所的な緩和を提供する局所代替薬へとシフトしています。スポーツやフィットネス文化の拡大、それに伴う身体活動への参加の増加は、スポーツ関連の怪我や筋肉疲労に対応する局所鎮痛剤への一貫した需要を生み出しています。しかし、市場は成長軌道を阻害しかねない大きな抑制要因に直面しています。新製品承認のための厳しい規制要件、特に処方箋製剤は市場参入の障壁となり、製薬会社の開発コストを増大させます。局所用製剤の浸透深度が限られているため、深部の痛みに対する有効性が制限され、市場範囲と消費者の採用が制限される可能性があります。特に新興市場では、消費者の価格感度が高く、高価格の革新的製品には課題があります。しかし、市場情勢には大きなチャンスも存在します。ナノテクノロジーに基づく製剤や浸透促進システムなど、先進的なドラッグデリバリー技術の開発は、治療効果の向上と用途拡大の機会をもたらします。天然素材やオーガニックの鎮痛剤に対する需要の高まりは、植物由来の製剤やクリーンラベルの代替品にニッチを創出しています。アジア太平洋とラテンアメリカの新興市場は、ヘルスケア支出の増加、疼痛管理に対する意識の高まり、購買力の高い中流階級の人口拡大により、大きな成長の可能性を秘めています。

本調査の主な特徴

• 本レポートでは、世界の局所鎮痛剤市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模と年間平均成長率（CAGR%）を掲載しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の局所鎮痛剤市場の主要企業をプロファイルしています。
• 本レポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
• 利害関係者は、世界の局所鎮痛剤市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 世界の局所鎮痛剤市場：薬剤クラス別、2020～2032年

• 非オピオイド系局所鎮痛剤
• オピオイド系局所鎮痛剤

第5章 世界の局所鎮痛剤市場：剤形別、2020～2032年

• クリーム
• ゲル
• スプレー
• パッチ
• 軟膏・バーム
• その他（ロールオン）

第6章 世界の局所鎮痛剤市場：治療用途別、2020～2032年

• 腰痛
• 筋肉痛
• 首の痛み
• 変形性関節症
• 片頭痛
• 頭痛・群発性頭痛
• 足底筋膜炎
• 坐骨神経痛
• 滑液包炎
• 慢性筋筋膜痛
• 肋軟骨炎
• 急性味覚障害
• 神経根障害
• 脊椎すべり症
• 顎関節症
• 腱炎
• 歯痛
• 糖尿病性末梢神経障害
• 関節リウマチ
• 炎症性疾患
• その他（術後疼痛など）

第7章 世界の局所鎮痛剤市場：疼痛タイプ別、2020～2032年

• 急性
• 慢性

第8章 世界の局所鎮痛剤市場：流通別、2020～2032年

• 市販薬（OTC）
• 処方箋に基づく

第9章 世界の局所鎮痛剤市場：薬剤タイプ別、2020～2032年

• 先発品
• ジェネリック

第10章 世界の局所鎮痛剤市場：薬剤組成別、2020～2032年

• 単剤
• 配合剤

第11章 世界の局所鎮痛剤市場：性別、2020～2032年

• 男性
• 女性

第12章 世界の局所鎮痛剤市場：年齢層別、2020～2032年

• 成人
• 小児
• 高齢者

第13章 世界の局所鎮痛剤市場：流通チャネル別、2020～2032年

• 病院薬局
• 小売薬局
• オンライン薬局

第14章 世界の局所鎮痛剤市場：地域別、2020～2032年

• 北米
  • 米国
  • カナダ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋地域
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 南アフリカ
  • 北アフリカ
  • 中央アフリカ

第15章 競合情勢

• Johnson & Johnson
• GlaxoSmithKline plc（Haleon）
• Sanofi
• Reckitt Benckiser Group plc
• Hisamitsu Pharmaceutical Co., Inc.
• Perrigo Company plc
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Viatris Inc.
• Boehringer Ingelheim International GmbH
• Endo International plc
• Topical BioMedics, Inc.
• The Mentholatum Company
• Pernix Therapeutics
• Hikma Pharmaceuticals PLC

第16章 アナリストの推奨事項

• 機会
• アナリストの見解
• Coherent Opportunity Map

第17章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Topical Analgesic Market is estimated to be valued at USD 12.10 Bn in 2025 and is expected to reach USD 18.56 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.3% from 2025 to 2032.

The global topical analgesic market represents a critical segment within the broader pain management pharmaceutical industry, encompassing a diverse range of externally applied therapeutic products designed to provide localized relief from various pain conditions. Topical analgesics, including creams, gels, patches, sprays, and ointments, deliver active pharmaceutical ingredients directly to affected areas through transdermal absorption, offering targeted pain relief while minimizing systemic exposure and associated side effects. This market serves multiple therapeutic applications, addressing acute and chronic pain conditions such as arthritis, muscle strains, back pain, neuropathic pain, and sports-related injuries. The increasing prevalence of musculoskeletal disorders, aging demographics, and growing consumer preference for non-invasive pain management alternatives have significantly contributed to market expansion. Key active ingredients driving market growth include menthol, capsaicin, salicylates, NSAIDs, and lidocaine, each offering distinct mechanisms of action for pain relief. The market encompasses both prescription and over-the-counter formulations, catering to diverse consumer needs and healthcare provider preferences. Technological advancements in drug delivery systems, including transdermal patches and nano-formulations, have enhanced product efficacy and patient compliance, further stimulating market development and creating opportunities for innovative therapeutic solutions.

Market Dynamics

The global topical analgesic market is primarily driven by several interconnected factors that collectively fuel sustained growth and market expansion. The increasing geriatric population worldwide, coupled with rising prevalence of chronic pain conditions such as arthritis, fibromyalgia, and neuropathic pain, creates substantial demand for effective topical pain management solutions. Growing awareness about the adverse effects of oral analgesics, including gastrointestinal complications and dependency risks, has shifted consumer and healthcare provider preferences toward topical alternatives that offer localized relief with reduced systemic exposure. The expanding sports and fitness culture, accompanied by increased participation in physical activities, generates consistent demand for topical analgesics addressing sports-related injuries and muscle fatigue. However, the market faces significant restraints that could impede growth trajectory. Stringent regulatory requirements for new product approvals, particularly for prescription formulations, create barriers to market entry and increase development costs for pharmaceutical companies. Limited penetration depth of topical formulations restricts their effectiveness for deep-seated pain conditions, potentially limiting market scope and consumer adoption. Price sensitivity among consumers, especially in emerging markets, poses challenges for premium-priced innovative products. Nevertheless, substantial opportunities exist within the market landscape. The development of advanced drug delivery technologies, including nanotechnology-based formulations and enhanced permeation systems, presents opportunities for improved therapeutic efficacy and expanded applications. Growing demand for natural and organic pain relief products creates niches for botanical-based formulations and clean-label alternatives. Emerging markets in Asia-Pacific and Latin America offer significant growth potential due to increasing healthcare spending, rising awareness about pain management, and expanding middle-class populations with greater purchasing power.

Key Features of the Study

• This report provides an in-depth analysis of the global topical analgesic market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global topical analgesic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline, Pfizer Inc., Novartis AG, Sanofi, Reckitt Benckiser, Teva Pharmaceutical Industries, Mylan N.V., Hisamitsu Pharmaceutical, and The Mentholatum Company.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global topical analgesic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global topical analgesic market.

Market Segmentation

• Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
  • Non-Opioid Topical Analgesics
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Diclofenac
  • Ibuprofen
  • Ketoprofen
  • Piroxicam
  • Capsaicin-Based Analgesics
  • Methyl Salicylate (Salicylates)
  • Lidocaine and Local Anesthetics
  • CGRP Inhibitors
  • Other Non-Opioid Agents
  • Opioid-Based Topical Analgesics
• Formulation Insights (Revenue, USD Bn, 2020 - 2032)
  • Creams
  • Gels
  • Sprays
  • Patches
  • Ointments & Balms
  • Others (Roll-Ons)
• Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Back Pain
  • Muscle Pain
  • Neck Pain
  • Osteoarthritis
  • Migraine
  • Headache and Cluster Headaches
  • Plantar Fasciitis
  • Sciatica
  • Bursitis
  • Chronic Myofascial Pain
  • Costochondritis
  • Gout, Acute
  • Radiculopathy
  • Spondylolisthesis
  • Temporomandibular Joint Disorder
  • Tendonitis
  • Toothache
  • Diabetic Peripheral Neuropathy
  • Rheumatoid Arthritis
  • Inflammatory Conditions
  • Others (Postoperative Pain, etc.)
• Pain Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Acute
  • Chronic
• Distribution Insights (Revenue, USD Bn, 2020 - 2032)
  • Over-the-Counter (OTC)
  • Prescription-Based
• Drug Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Brand
  • Generic
• Drug Composition Insights (Revenue, USD Bn, 2020 - 2032)
  • Single
  • Combination
• Male Insights (Revenue, USD Bn, 2020 - 2032)
  • Male
  • Female
• Age Group Insights (Revenue, USD Bn, 2020 - 2032)
  • Adult
  • Pediatric
  • Geriatric
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals Pharmacy
  • Retail Pharmacies
  • Online Pharmacies
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Johnson & Johnson
  • GlaxoSmithKline plc (Haleon)
  • Sanofi
  • Reckitt Benckiser Group plc
  • Hisamitsu Pharmaceutical Co., Inc.
  • Perrigo Company plc
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Boehringer Ingelheim International GmbH
  • Endo International plc
  • Topical BioMedics, Inc.
  • The Mentholatum Company
  • Pernix Therapeutics
  • Hikma Pharmaceuticals PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Topical Analgesic Market, By Drug Class
  • Global Topical Analgesic Market, By Formulation
  • Global Topical Analgesic Market, By Therapeutic Application
  • Global Topical Analgesic Market, By Pain Type
  • Global Topical Analgesic Market, By Distribution
  • Global Topical Analgesic Market, By Drug Type
  • Global Topical Analgesic Market, By Drug Composition
  • Global Topical Analgesic Market, By Gender
  • Global Topical Analgesic Market, By Age Group
  • Global Topical Analgesic Market, By Distribution Channel
  • Global Topical Analgesic Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Topical Analgesic Market, By Drug Class, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Non-Opioid Topical Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
      • Diclofenac
      • Ibuprofen
      • Ketoprofen
      • Piroxicam
    • Capsaicin-Based Analgesics
    • Methyl Salicylate (Salicylates)
    • Lidocaine and Local Anesthetics
    • CGRP Inhibitors
    • Other Non-Opioid Agents
• Opioid-Based Topical Analgesics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Topical Analgesic Market, By Formulation, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Creams
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gels
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sprays
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Patches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ointments & Balms
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Roll-Ons)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Topical Analgesic Market, By Therapeutic Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Back Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Muscle Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neck Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Osteoarthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Migraine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Headache and Cluster Headaches
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Plantar Fasciitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Sciatica
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bursitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Myofascial Pain
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Costochondritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Gout, Acute
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radiculopathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Spondylolisthesis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Temporomandibular Joint Disorder
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tendonitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Toothache
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetic Peripheral Neuropathy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rheumatoid Arthritis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammatory Conditions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Postoperative Pain, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Topical Analgesic Market, By Pain Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Acute
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Topical Analgesic Market, By Distribution, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Over-the-Counter (OTC)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prescription-Based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Topical Analgesic Market, By Drug Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Brand
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Generic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Topical Analgesic Market, By Drug Composition, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Single
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Combination
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Topical Analgesic Market, By Gender, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Male
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Female
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Topical Analgesic Market, By Age Group, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Geriatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Topical Analgesic Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals Pharmacy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

14. Global Topical Analgesic Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Pain Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Composition, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Gender , 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

15. Competitive Landscape

• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc (Haleon)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sanofi
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Reckitt Benckiser Group plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hisamitsu Pharmaceutical Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Perrigo Company plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Viatris Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Endo International plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Topical BioMedics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• The Mentholatum Company
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pernix Therapeutics
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Hikma Pharmaceuticals PLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

16. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

17. References and Research Methodology

• References
• Research Methodology
• About us